Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by gamma interferon-induced indoleamine 2,3-dioxygenase activity

Infection and Immunity

Volumn 68, Issue 11, 2000, Pages 6478-6481

  Pantoja, L G ^a   Miller, R D ^a   Ramirez, J A ^a   Molestina, R E ^a   Summersgill, J T ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE;

ARTICLE; ATHEROSCLEROSIS; CHLAMYDIA PNEUMONIAE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; DRUG MECHANISM; ENZYME INDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; VASCULAR SMOOTH MUSCLE;

AORTA; ARTERIOSCLEROSIS; CELLS, CULTURED; CHLAMYDOPHILA PNEUMONIAE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMAN; INTERFERON TYPE II; MUSCLE, SMOOTH, VASCULAR; TRYPTOPHAN OXYGENASE;

EID: 0033792967     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.11.6478-6481.2000     Document Type: Article

References (28)

1. Persistent chlamydiae: From cell culture to a paradigm for chlamydial pathogenesis
2. Reactivation of persistent Chlamydia trachomatis infection in cell culture
3. Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence
4. 1-Methyl-DL-tryptophan, β-(3-benzofuranyl)-DS-alanine (the oxygen analog of tryptophan), and β-[3-benzo(b)thienyl]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase
5. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues
6. Chlamydia pneumoniae infection of human endothelial cells induces proliferation of smooth muscle cells via an endothelial cell-derived soluble factor(s)
7. Chlamydia species infect human vascular endothelial cells and induce procoagulant activity
8. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells
9. In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae
10. C. pneumoniae strain TWAR pneumonia
11. Chronic infection in the etiology of atherosclerosis - The case for Chlamydia pneumoniae
12. Antiparasitic and antiproliferative effects of indoleamine 2,3-dioxygenase enzyme expression in human fibroblasts
13. Interleukin-1 enhances indoleamine 2,3-dioxygenase activity by increasing specific mRNA expression in human mononuclear phagocytes
14. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen
15. Chlamydia pneumoniae multiplies in human endothelial cells in vitro
16. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries
17. Chlamydia pneumoniae (TWAR)
18. A review of Chlamydia pneumoniae and atherosclerosis
19. Inhibition of Chlamydia pneumoniae replication in HEp-2 cells by interferon-γ: Role of tryptophan catabolism
20. Infection of human endothelial cells with Chlamydia pneumoniae stimulates transendothelial migration of neutrophils and monocytes
21. Chlamydiae as pathogens: New species and new issues
22. Interferon-γ blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan
23. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis
24. Cytotoxic-T-lymphocyte-mediated cytolysis of L cells persistently infected with Chlamydia spp
25. The pathogenesis of atherosclerosis: An overview
26. Inhibition of Chlamydia pneumoniae growth in HEp-2 cells pretreated with gamma interferon and tumor necrosis factor alpha
27. The immunobiology and immunopathology of chlamydial infections
28. Ultrastructural analysis of developmental events in Chlamydia pneumoniae-infected cells